Heart Transplantation for Cardiac Amyloidosis: Mayo Clinic Consensus Statement
Melissa A Lyle1, Julie L Rosenthal2, Jose N Nativi Nicolau1
1Division of Advanced Heart Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, FL.
Cardiac amyloidosis (CA) involves amyloid deposits in the heart, worsening prognosis. This study proposes guidelines for heart transplantation in CA patients, addressing pre- and post-transplant care.
Area of Science:
- Cardiology
- Cardiovascular Research
- Amyloidosis Research
Background:
- Cardiac amyloidosis (CA) is a serious condition where amyloid proteins deposit in the heart muscle.
- The most common types are AL and ATTR amyloidosis, both leading to infiltrative cardiomyopathy.
- Cardiac involvement significantly worsens patient prognosis, especially in advanced heart failure.
More Related Videos
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
